Renaissance Technologies LLC Buys 315,046 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Renaissance Technologies LLC grew its stake in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 2,032.6% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 330,546 shares of the company's stock after buying an additional 315,046 shares during the quarter. Renaissance Technologies LLC owned 0.19% of Option Care Health worth $7,669,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in OPCH. Murphy & Mullick Capital Management Corp bought a new position in shares of Option Care Health during the 4th quarter valued at $26,000. UMB Bank n.a. raised its holdings in shares of Option Care Health by 41.7% during the fourth quarter. UMB Bank n.a. now owns 1,176 shares of the company's stock valued at $27,000 after acquiring an additional 346 shares in the last quarter. Signaturefd LLC boosted its stake in shares of Option Care Health by 487.9% during the 4th quarter. Signaturefd LLC now owns 1,211 shares of the company's stock valued at $28,000 after purchasing an additional 1,005 shares in the last quarter. Quadrant Capital Group LLC grew its stake in Option Care Health by 172.8% in the fourth quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company's stock worth $40,000 after purchasing an additional 1,099 shares during the period. Finally, Blue Trust Inc. lifted its position in Option Care Health by 16.9% during the fourth quarter. Blue Trust Inc. now owns 4,703 shares of the company's stock valued at $109,000 after buying an additional 681 shares during the period. 98.05% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Option Care Health

In other news, insider Michael Bavaro sold 30,996 shares of the company's stock in a transaction dated Friday, February 28th. The shares were sold at an average price of $33.26, for a total value of $1,030,926.96. Following the transaction, the insider now directly owns 44,974 shares in the company, valued at approximately $1,495,835.24. This represents a 40.80 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. 0.64% of the stock is currently owned by insiders.

Option Care Health Price Performance

Shares of NASDAQ:OPCH traded up $0.21 on Thursday, reaching $32.32. The company's stock had a trading volume of 761,314 shares, compared to its average volume of 1,780,073. The company has a 50-day simple moving average of $33.33 and a 200 day simple moving average of $28.70. Option Care Health, Inc. has a 52-week low of $21.39 and a 52-week high of $35.53. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. The company has a market cap of $5.31 billion, a P/E ratio of 27.14, a PEG ratio of 2.30 and a beta of 1.07.

Analysts Set New Price Targets

OPCH has been the topic of several research reports. JPMorgan Chase & Co. boosted their price objective on shares of Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a research note on Thursday, March 6th. JMP Securities reissued a "market outperform" rating and issued a $36.00 target price on shares of Option Care Health in a report on Tuesday. Barrington Research restated an "outperform" rating and set a $38.00 price objective on shares of Option Care Health in a research note on Monday. Bank of America upgraded shares of Option Care Health from a "neutral" rating to a "buy" rating and upped their target price for the stock from $26.00 to $33.00 in a research note on Monday, January 13th. Finally, Jefferies Financial Group raised Option Care Health from a "hold" rating to a "buy" rating and upped their price objective for the company from $26.00 to $35.00 in a research report on Thursday, January 23rd. Two research analysts have rated the stock with a hold rating and six have given a buy rating to the company's stock. According to data from MarketBeat, Option Care Health presently has an average rating of "Moderate Buy" and a consensus price target of $33.75.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.